Literature DB >> 11486241

Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers.

W S Waring1, D J Webb, S R Maxwell.   

Abstract

Oxidative stress plays an important role in the development of atherosclerosis and contributes to tissue damage that occurs as a consequence, particularly in myocardial infarction and acute stroke. Antioxidant properties of uric acid have long been recognized and, as a result of its comparatively high serum concentrations, it is the most abundant scavenger of free radicals in humans. Elevation of serum uric acid concentration occurs as a physiologic response to increased oxidative stress-for example, during acute exercise-thus providing a counter-regulatory increase in antioxidant defenses. In view of its antioxidant properties, uric acid may have potentially important and beneficial effects within the cardiovascular system. We wished to investigate whether administration of uric acid was feasible and if it could have an impact on antioxidant function in vivo. We have, therefore, performed a randomized, placebo-controlled double-blind study of the effects of systemic administration of uric acid, 1,000 mg, in healthy volunteers, compared with vitamin C, 1,000 mg. We observed a significant increase in serum free-radical scavenging capacity from baseline during uric acid and vitamin C infusion, using two methodologically distinct antioxidant assays. The effect of uric acid was substantially greater than that of vitamin C.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486241     DOI: 10.1097/00005344-200109000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  84 in total

Review 1.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

2.  Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.

Authors:  Richard J Johnson; Miguel A Lanaspa; Eric A Gaucher
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 3.  Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers.

Authors:  Lars O Dragsted
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

4.  Acute kidney injury after acute gastroenteritis in an infant with hereditary hypouricemia.

Authors:  Koichi Kamei; Masao Ogura; Shingo Ishimori; Hiroshi Kaito; Kazumoto Iijima; Shuichi Ito
Journal:  Eur J Pediatr       Date:  2013-05-08       Impact factor: 3.183

5.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

6.  Uric Acid Neuroprotection Associated to IL-6/STAT3 Signaling Pathway Activation in Rat Ischemic Stroke.

Authors:  Alicia Aliena-Valero; Sergio Rius-Pérez; Júlia Baixauli-Martín; Germán Torregrosa; Ángel Chamorro; Salvador Pérez; Juan B Salom
Journal:  Mol Neurobiol       Date:  2020-09-22       Impact factor: 5.590

Review 7.  Effect of uric acid in animal models of ischemic stroke: A systematic review and meta-analysis.

Authors:  Alicia Aliena-Valero; Júlia Baixauli-Martín; María Castelló-Ruiz; Germán Torregrosa; David Hervás; Juan B Salom
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-19       Impact factor: 6.200

8.  Vascular Function and Uric Acid-Lowering in Stage 3 CKD.

Authors:  Diana I Jalal; Emily Decker; Loni Perrenoud; Kristen L Nowak; Nina Bispham; Tapan Mehta; Gerard Smits; Zhiying You; Douglas Seals; Michel Chonchol; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121

9.  The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.

Authors:  Peter Higgins; Jesse Dawson; Matthew Walters
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-11-04

10.  Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke?

Authors:  Bin Zhang; Cong Gao; Ning Yang; WeiZhi Zhang; XingWang Song; JianRui Yin; ShuXiang Pu; YongHong Yi; QingChun Gao
Journal:  BMC Neurol       Date:  2010-09-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.